Pcaf Modulates Polyglutamine Pathology in a Drosophila Model of Huntington’s Disease

Publisher： Karger

E-ISSN： 1660-2862|9|2|104-106

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.9, Iss.2, 2011-09, pp. : 104-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Huntington’s Disease – New Perspectives Based on Neuroendocrine Changes in Rodent Models

Neurodegenerative Diseases, Vol. 6, Iss. 4, 2009-06 ,pp. : 154-164

Karger

Access to resources Recommend Favorite

Impaired Brain Creatine Kinase Activity in Huntington’s Disease

Neurodegenerative Diseases, Vol. 8, Iss. 4, 2010-12 ,pp. : 194-201

Karger

Access to resources Recommend Favorite

Impaired Ideomotor Limb Apraxia in Cortical and Subcortical Dementia: A Comparison of Alzheimer’s and Huntington’s Disease

Neurodegenerative Diseases, Vol. 8, Iss. 4, 2011-01 ,pp. : 208-215

Karger

Access to resources Recommend Favorite

Truncated Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α Splice Variant Is Severely Altered in Huntington’s Disease

Neurodegenerative Diseases, Vol. 8, Iss. 6, 2011-07 ,pp. : 496-503

Karger

Access to resources Recommend Favorite

N-Acetylcysteine Reverses Mitochondrial Dysfunctions and Behavioral Abnormalities in 3-Nitropropionic Acid-Induced Huntington’s Disease

Neurodegenerative Diseases, Vol. 9, Iss. 3, 2012-02 ,pp. : 145-157

Karger

Access to resources Recommend Favorite